Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) EPS (Basic) (2018 - 2025)

Historic EPS (Basic) for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to -$4.83.

  • Dna X's EPS (Basic) rose 4817.6% to -$4.83 in Q3 2025 from the same period last year, while for Sep 2025 it was $33.83, marking a year-over-year increase of 38914.53%. This contributed to the annual value of -$7.27 for FY2024, which is 3624270.36% down from last year.
  • As of Q3 2025, Dna X's EPS (Basic) stood at -$4.83, which was up 4817.6% from -$0.79 recorded in Q2 2025.
  • Dna X's EPS (Basic)'s 5-year high stood at $0.12 during Q2 2023, with a 5-year trough of -$9.32 in Q3 2024.
  • Its 5-year average for EPS (Basic) is -$1.39, with a median of -$0.38 in 2022.
  • Per our database at Business Quant, Dna X's EPS (Basic) soared by 40000.0% in 2023 and then plummeted by 786666.67% in 2024.
  • Quarter analysis of 5 years shows Dna X's EPS (Basic) stood at -$0.36 in 2021, then skyrocketed by 88.61% to -$0.04 in 2022, then plummeted by 680.13% to -$0.32 in 2023, then crashed by 1374.36% to -$4.72 in 2024, then dropped by 2.37% to -$4.83 in 2025.
  • Its EPS (Basic) stands at -$4.83 for Q3 2025, versus -$0.79 for Q2 2025 and $0.08 for Q1 2025.